The 10 mg product’s recorded first authorisation was November 1990. This is a product milestone, not a discovery date.
A product's first authorisation is not the discovery date of the molecule. The UK adult indication wording and modern MHRA communication provide the relevant current context, while historical Anafranil recognition remains useful for finding the article.
The Oxford Health NHS formulary's indexed entry reports that sustained-release Anafranil SR preparations were discontinued in the UK. A reference to a 75 mg sustained-release tablet in another product's label therefore does not establish current supply. This record does not claim a current licensed UK 75 mg sustained-release product or infer foreign-product equivalence.